What challenges have patients faced with medical cannabis use for PMR?

PostedFebruary 23, 2026

UpdatedFebruary 23, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

While medical cannabis offers potential relief for PMR symptoms, patients often encounter obstacles in accessing and using it effectively. Understanding these difficulties can help guide better treatment strategies. Challenges with medical cannabis for PMR range from logistical barriers to health considerations.

Common Patient Challenges

Patients report several recurring issues when using cannabis for PMR.

Access Barriers

Access barriers are common, including difficulty obtaining prescriptions, limited dispensary locations, or regional restrictions. These obstacles can delay treatment and reduce the ability to maintain consistent symptom management.

Side Effects

Managing side effects is another challenge. Patients may experience dizziness, fatigue, or changes in mood, requiring careful monitoring and dose adjustments to maintain both safety and comfort.

Legal or Cost Issues

Legal or cost issues can also impede use. Variations in local laws, insurance coverage limitations, and high costs of medical cannabis make it harder for some patients to adhere to treatment plans.

By recognising challenges with medical cannabis for PMR, including access barriers, side effects, and legal or cost issues, healthcare providers and patients can work together to address these obstacles. This ensures safer, more effective use and better overall management of PMR symptoms.

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.